These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 7317574)

  • 1. Comparative binding affinities of tamoxifen, 4-hydroxytamoxifen, and desmethyltamoxifen for estrogen receptors isolated from human breast carcinoma: correlation with blood levels in patients with metastatic breast cancer.
    Fabian C; Tilzer L; Sternson L
    Biopharm Drug Dispos; 1981; 2(4):381-90. PubMed ID: 7317574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioactivities, estrogen receptor interactions, and plasminogen activator-inducing activities of tamoxifen and hydroxy-tamoxifen isomers in MCF-7 human breast cancer cells.
    Katzenellenbogen BS; Norman MJ; Eckert RL; Peltz SW; Mangel WF
    Cancer Res; 1984 Jan; 44(1):112-9. PubMed ID: 6537799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implications of tamoxifen metabolism in the athymic mouse for the study of antitumor effects upon human breast cancer xenografts.
    Robinson SP; Langan-Fahey SM; Jordan VC
    Eur J Cancer Clin Oncol; 1989 Dec; 25(12):1769-76. PubMed ID: 2632258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiestrogenic action of 3-hydroxytamoxifen in the human breast cancer cell line MCF-7.
    Roos W; Oeze L; Löser R; Eppenberger U
    J Natl Cancer Inst; 1983 Jul; 71(1):55-9. PubMed ID: 6575210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiestrogenic potency and binding characteristics of the triphenylethylene H1285 in MCF-7 human breast cancer cells.
    Sheen YY; Ruh TS; Mangel WF; Katzenellenbogen BS
    Cancer Res; 1985 Sep; 45(9):4192-9. PubMed ID: 4040807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiestrogen binding in antiestrogen growth-resistant estrogen-responsive clonal variants of MCF-7 human breast cancer cells.
    Miller MA; Lippman ME; Katzenellenbogen BS
    Cancer Res; 1984 Nov; 44(11):5038-45. PubMed ID: 6488162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tamoxifen and metabolites in MCF7 cells: correlation between binding to estrogen receptor and inhibition of cell growth.
    Coezy E; Borgna JL; Rochefort H
    Cancer Res; 1982 Jan; 42(1):317-23. PubMed ID: 7053859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and biological activity of tamoxifen metabolites in human serum.
    Kemp JV; Adam HK; Wakeling AE; Slater R
    Biochem Pharmacol; 1983 Jul; 32(13):2045-52. PubMed ID: 6870933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination and pharmacology of a new hydroxylated metabolite of tamoxifen observed in patient sera during therapy for advanced breast cancer.
    Jordan VC; Bain RR; Brown RR; Gosden B; Santos MA
    Cancer Res; 1983 Mar; 43(3):1446-50. PubMed ID: 6825112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of phase I and phase II metabolites of tamoxifen in breast cancer patients.
    Poon GK; Chui YC; McCague R; Lłnning PE; Feng R; Rowlands MG; Jarman M
    Drug Metab Dispos; 1993; 21(6):1119-24. PubMed ID: 7905393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acquired tamoxifen resistance: correlation with reduced breast tumor levels of tamoxifen and isomerization of trans-4-hydroxytamoxifen.
    Osborne CK; Coronado E; Allred DC; Wiebe V; DeGregorio M
    J Natl Cancer Inst; 1991 Oct; 83(20):1477-82. PubMed ID: 1920493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolites of tamoxifen in animals and man: identification, pharmacology, and significance.
    Jordan VC
    Breast Cancer Res Treat; 1982; 2(2):123-38. PubMed ID: 6184101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolites, pharmacodynamics, and pharmacokinetics of tamoxifen in rats and mice compared to the breast cancer patient.
    Robinson SP; Langan-Fahey SM; Johnson DA; Jordan VC
    Drug Metab Dispos; 1991; 19(1):36-43. PubMed ID: 1673419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-function relationships of hydroxylated metabolites of tamoxifen that control the proliferation of estrogen-responsive T47D breast cancer cells in vitro.
    Murphy CS; Langan-Fahey SM; McCague R; Jordan VC
    Mol Pharmacol; 1990 Nov; 38(5):737-43. PubMed ID: 2233701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogen-receptor binding and biologic activity of tamoxifen and its metabolites.
    Wakeling AE; Slater SR
    Cancer Treat Rep; 1980; 64(6-7):741-4. PubMed ID: 7427959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endoxifen (4-hydroxy-N-desmethyl-tamoxifen) has anti-estrogenic effects in breast cancer cells with potency similar to 4-hydroxy-tamoxifen.
    Lim YC; Desta Z; Flockhart DA; Skaar TC
    Cancer Chemother Pharmacol; 2005 May; 55(5):471-8. PubMed ID: 15685451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tamoxifen metabolites in patients on long-term adjuvant therapy for breast cancer.
    Langan-Fahey SM; Tormey DC; Jordan VC
    Eur J Cancer; 1990; 26(8):883-8. PubMed ID: 2145931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of oestrogen receptor status and time on the intra-tumoural accumulation of tamoxifen and N-desmethyltamoxifen following short-term therapy in human primary breast cancer.
    Johnston SR; Haynes BP; Sacks NP; McKinna JA; Griggs LJ; Jarman M; Baum M; Smith IE; Dowsett M
    Breast Cancer Res Treat; 1993 Dec; 28(3):241-50. PubMed ID: 8018953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The steady-state pharmacokinetics of tamoxifen and its metabolites in breast cancer patients.
    Soininen K; Kleimola T; Elomaa I; Salmo M; Rissanen P
    J Int Med Res; 1986; 14(3):162-5. PubMed ID: 3522312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-activity relationships of nonisomerizable derivatives of tamoxifen: importance of hydroxyl group and side chain positioning for biological activity.
    Murphy CS; Parker CJ; McCague R; Jordan VC
    Mol Pharmacol; 1991 Mar; 39(3):421-8. PubMed ID: 2005879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.